UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (12), p.1652-1660

2018

Volltextzugriff (PDF)

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)

BMC cancer, 2020-02, Vol.20 (1), p.117-117, Article 117

2020

Volltextzugriff (PDF)

Integrating bevacizumab and radiation treatment of brain metastasis: is there sense and sensibility in this approach?

Annals of translational medicine, 2016-01, Vol.4 (2), p.36-36

2016

Volltextzugriff (PDF)

A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS

Clinical and translational radiation oncology, 2021-07, Vol.29, p.27-32

2021

Volltextzugriff (PDF)

Indirect cell death and the LQ model in SBRT and SRS

Journal of radiosurgery and SBRT, 2020, Vol.7 (1), p.1-4

2020

Volltextzugriff (PDF)

Brain Metastasis—A Multidisciplinary Approach

International Journal of Radiation Oncology, Biology, Physics, 2009, Vol.75 (4), p.1273-1273

Sperduto, Paul W., M.D., M.P.P

2009

Volltextzugriff (PDF)

Cumulative Doses to Brain and Other Critical Structures After Multisession Gamma Knife Stereotactic Radiosurgery for Treatment of Multiple Metastatic Tumors

Frontiers in oncology, 2018-03, Vol.8, p.65-65

2018

Volltextzugriff (PDF)

Reply to Drs. Mulvenna and Holt

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.1194-1195

2011

Volltextzugriff (PDF)

In Reply to Drs. Nieder and Molls

International journal of radiation oncology, biology, physics, 2008-12, Vol.72 (5), p.1619-1619

2008

Volltextzugriff (PDF)

Targeted therapy strategies for melanoma brain metastasis

Neuro-oncology advances, 2021-11, Vol.3 (Supplement_5), p.v75-v85

2021

Volltextzugriff (PDF)

Gamma knife stereotactic radiosurgery for renal cell carcinoma and melanoma brain metastases-comparison of dose response

Journal of radiosurgery and SBRT, 2013, Vol.2 (3), p.193-207

2013

Volltextzugriff (PDF)

In Reply to Drs. Weltman and Brandt

International journal of radiation oncology, biology, physics, 2008-03, Vol.70 (4), p.1292-1293

2008

Volltextzugriff (PDF)

The accuracy of predicting survival in individual patients with cancer: Clinical article

Journal of neurosurgery, 2014-01, Vol.120 (1), p.24-30

2014

Volltextzugriff (PDF)

Tumor Cavity Shape Characteristics Do Not Predict Local Control in Patients with Resected Brain Metastases Receiving Adjuvant SRS

International journal of radiation oncology, biology, physics, 2019-04, Vol.103 (5), p.E39

2019

Volltextzugriff (PDF)

P51 - Tumor Cavity Shape Characteristics Do Not Predict Local Control in Patients with Resected Brain Metastases Receiving Adjuvant SRS

International journal of radiation oncology, biology, physics, 2019-04, Vol.103 (5), p.E39-E39

2019

Volltextzugriff (PDF)

RADT-04 IMPROVED SURVIVAL IN PATIENTS WITH RADIONECROSIS VS. LOCAL RECURRENCE AFTER STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES

Neuro-oncology advances, 2024-08, Vol.6 (Supplement_1), p.i30-i30

2024

Volltextzugriff (PDF)

Tumor subtype and other prognostic factors in breast cancer patients with brain metastases: The updated graded prognostic assessment (Breast-GPA)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.1079-1079

2019

Volltextzugriff (PDF)

CTNI-05. NRG ONCOLOGY / RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY / STEREOTACTIC RADIOSURGERY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASES FROM HER2-POSITIVE BREAST CANCER

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii42-ii42

2020

Volltextzugriff (PDF)

ACTR-38. NRG/RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM Her2-POSITIVE BREAST CANCER: A COLLABORATIVE STUDY OF NRG AND KROG (NCT01622868)

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi10-vi10

2016

Volltextzugriff (PDF)

Validation of the Graded Prognostic Assessment and Recursive Partitioning Analysis as prognostic tools using a modern cohort of patients with brain metastases

Neuro-oncology practice, 2024-06

2024

Volltextzugriff (PDF)

Adjuvant Radiation Therapy, Androgen Deprivation and Docetaxel for High-risk Prostate Cancer Post-prostatectomy: Results of NRG Oncology RTOG 0621

Cancer, 2017-03, Vol.123 (13), p.2489-2496

2017

Volltextzugriff (PDF)

BM-13THE (F)UTILITY OF PREDICTIVE MODELS

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v34-v35

2014

Volltextzugriff (PDF)

BM-38THE PREFERRED ANATOMIC DISTRIBUTION OF 1172 BRAIN METASTASES BASED ON BRAIN VOLUME AND REGIONAL BLOOD FLOW

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v40-v40

2014

Volltextzugriff (PDF)

BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi27-vi27

2016

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

KollektionSpringerLink Series

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(46)
Buchkapitel
(4)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)

Integrating bevacizumab and radiation treatment of brain metastasis: is there sense and sensibility in this approach?

A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS

Indirect cell death and the LQ model in SBRT and SRS

Brain Metastasis—A Multidisciplinary Approach

Cumulative Doses to Brain and Other Critical Structures After Multisession Gamma Knife Stereotactic Radiosurgery for Treatment of Multiple Metastatic Tumors

Reply to Drs. Mulvenna and Holt

In Reply to Drs. Nieder and Molls

Targeted therapy strategies for melanoma brain metastasis

Gamma knife stereotactic radiosurgery for renal cell carcinoma and melanoma brain metastases-comparison of dose response

In Reply to Drs. Weltman and Brandt

The accuracy of predicting survival in individual patients with cancer: Clinical article

Tumor Cavity Shape Characteristics Do Not Predict Local Control in Patients with Resected Brain Metastases Receiving Adjuvant SRS

P51 - Tumor Cavity Shape Characteristics Do Not Predict Local Control in Patients with Resected Brain Metastases Receiving Adjuvant SRS

RADT-04 IMPROVED SURVIVAL IN PATIENTS WITH RADIONECROSIS VS. LOCAL RECURRENCE AFTER STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES

Tumor subtype and other prognostic factors in breast cancer patients with brain metastases: The updated graded prognostic assessment (Breast-GPA)

CTNI-05. NRG ONCOLOGY / RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY / STEREOTACTIC RADIOSURGERY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASES FROM HER2-POSITIVE BREAST CANCER

ACTR-38. NRG/RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM Her2-POSITIVE BREAST CANCER: A COLLABORATIVE STUDY OF NRG AND KROG (NCT01622868)

Validation of the Graded Prognostic Assessment and Recursive Partitioning Analysis as prognostic tools using a modern cohort of patients with brain metastases

Adjuvant Radiation Therapy, Androgen Deprivation and Docetaxel for High-risk Prostate Cancer Post-prostatectomy: Results of NRG Oncology RTOG 0621

BM-13THE (F)UTILITY OF PREDICTIVE MODELS

BM-38THE PREFERRED ANATOMIC DISTRIBUTION OF 1172 BRAIN METASTASES BASED ON BRAIN VOLUME AND REGIONAL BLOOD FLOW

BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)

Aktive Filter

Suchergebnisse filtern